About 10% of 100 clinical isolates of Enterococcusfaecalis were resistant to .25 ,ug of norfloxacin, ofloxacin, ciprofloxacin, and temafloxacin per ml. In this study, the DNA gyrase of E. faecalis was purified from a fluoroquinolone-susceptible strain (ATCC 19433) Experiments that combined heterologous gyrase subunits showed that the A subunit from either of the resistant isolates conferred resistance to fluoroquinolones. These findings indicate that an alteration in the gyrase A subunit is the major contributor to fluoroquinolone resistance in E. faecalis clinical isolates. A difference in drug uptake may also contribute to the level of fluoroquinolone resistance in these isolates.
The fluoroquinolones, such as norfloxacin, ofloxacin, ciprofloxacin, and others, have increasingly been used clinically because of their potent and broad antibacterial activities (18, 43) . Studies with Escherichia coli and other gram-negative bacteria have shown that fluoroquinolones exert their antibacterial activities by inhibiting DNA gyrase (43, 44) , an essential bacterial topoisomerase which converts relaxed DNA to the supercoiled form (8, 40) . Generally, the in vitro inhibitory effects of fluoroquinolones on the supercoiling activity of E. coli DNA gyrase closely correlate with their antibacterial activities (19, 24, 37) , although the mechanisms which lead to fluoroquinolone-mediated bacterial killing are not fully understood (5, 19) .
Even though the frequency of resistance to fluoroquinolones in vitro is much lower than those of nalidixic acid and oxolinic acid (22, 32, 43) , the number of fluoroquinoloneresistant strains has increased clinically, especially with bacterial species such as Pseudomonas aeruginosa, Serratia marcescens, and Staphylococcus aureus (32) . The resistance to fluoroquinolones in gram-negative bacteria such as E. coli and P. aeruginosa has been shown to be associated with modification of DNA gyrase or alteration of outer membrane permeability (3, 17, 19, 22, 28, 32, 35, 43) . For gram-positive bacteria, the role of DNA gyrase in the antibacterial action of fluoroquinolones has been unclear, although DNA gyrase has been partially purified from Bacillus subtilis (33, 39) , Micrococcus luteus (27) , and S. aureus (41) . For example, Fu et al. (10) reported that fluoroquinolones are poor inhibitors of the supercoiling activity of M. luteus gyrase at or near the MICs. Both novobiocin and coumermycin A1, which are known to be inhibitors of the B subunit of DNA * Corresponding author.
t Present address: Biological Research Laboratory, Tanabe Seiyaku Co., Ltd., 2-2-50 Kawagishi, Toda, Saitama 335, Japan. gyrase (20) , fully inhibited the gyrase. Georgopapadakou and Dix (14) reported similar observations on the relation between the inhibitory actions of fluoroquinolones against S. aureus gyrase and their MICs for S. aureus.
We have been surveying the susceptibilities of grampositive bacteria to fluoroquinolones and have found that the MICs for Enterococcus faecalis isolates have gradually increased for clinical isolates. Although E. faecalis is resistant to the old quinolones (15) , fluoroquinolones such as ciprofloxacin (4, 25) and temafloxacin (31) have promising activity for the treatment of urinary tract infections. However, the MICs of these fluoroquinolones for E. faecalis are too close to the concentrations achievable in plasma (30, 34) , presumably contributing to the emergence of fluoroquinolone resistance in E. faecalis. E. faecalis DNA gyrase has not previously been characterized, and the mechanisms of resistance to fluoroquinolones have not been studied.
We report the purification and some properties of DNA gyrase from E. faecalis and the inhibitory effects of fluoroquinolones on the supercoiling activity of the gyrase from a quinolone-susceptible strain and two quinolone-resistant isolates. We also examined quinolone uptake by these strains. (2) .
MATERIALS
DNA supercoiling assay and IC50 determinations. The assay of DNA gyrase subunits was modified from those described previously (13, 29) . One unit of gyrase was defined'as the amount of enzyme that catalyzed the conversion of one-half of 0.1 ,ug of relaxed closed circular pBR322 DNA to the supercoiled form in 1 h at 37°C, as discerned by agarose gel electrophoresis (13) . Plasmid pBR322 was relaxed by topoisomerase I by the recommended protocol of the manufacturer. DNA gyrase supercoiling activity was assayed as described previously (11, 12, 37) . Briefly, the standard reaction mixture (20 pl) contained 20 mM Tris hydrochloride (pH 7.5), 20 mM KCl, 2 mM MgCl2, 2 mM spermidine, 2 mM ATP, 1 mM DTT, 10 ,ug of bovine serum albumin per ml, 30 ,ug of tRNA per ml, 0.1 ,ug of relaxed pBR322, drug solution, and DNA gyrase subunits A and B (1 U each). A control reaction without drug was included. After incubation at 37°C for 1 h, the reaction was stopped by the addition of 3 ,ul of proteinase K (1 mg/ml), and then the reaction mixture was subjected to agarose gel electrophoresis (0.8% agarose in 40 mM Tris acetate-2 mM EDTA). The gel was stained in 0.5 ,ug of ethidium bromide per ml and photographed upon exposure to UV light. The negative was traced with a densitometer (CS-9000; Shimadzu Seisakusho' Co., Ltd.). Densitometer tracings of negatives were used to determine the IC5Os. The IC50 was defined as the concentration of drug that inhibited 50% of the supercoiling activity of DNA gyrase in a standard reaction mixture.
Norfloxacin uptake by E. faecalis. The uptake of norfloxacin by intact cells was measured essentially as described by Hirai et al. (17) . E. faecalis cells were grown to the late log phase in tr'yptic soy broth, and norfloxacin was added to the culture at a final concentration of 10 ,ug/ml. At various time intervals, 10 ml of the culture was rapidly chilled and washed once with 2 ml of ice-cold saline; the final pellet was suspended in 1 ml of 5% acetic acid solution. Cell-associated norfloxacin was extracted by heating the cells in a boilingwater bath for 7 min. The concentration of norfloxacin in the supernatant was quantitated at 270 nm by high-performance liquid chromatography by using a YMC-A312 column (YMC Co., Ltd.) and a mobile phase of 5% acetic acid-methanol (85:15; vol/vol) (42) .
RESULTS
Susceptibility to quinolones and other antimicrobial agents. A total of 100 urinary isolates of E. faecalis collected from several hospitals throughout Japan in 1989 were tested for their quinolone susceptibilities. Although the susceptibilities to the fluoroquinolones were broad, about 10% of these strains were resistant to .25 ,ug of any fluoroquinolone per ml (Table 1) . Among the fluoroquinolone-resistant isolates, two isolates, MS16968 and MS16996, were randomly selected for further studies. The susceptibilities of these two clinical isolates and ATCC 19433, a fluoroquinolone-susceptible strain, to quinolones and other antimicrobial agents are presented in Table 2 . ATCC 19433 was intrinsically resistant to nalidixic acid, pipemidic acid, and a cephalosporin, ceftazidime, but was susceptible to fluoroquinolones, novobiocin, chloramphenicol, tetracycline, and ampicillin. On the other hand, MS16968 and MS16996 were highly and moderately resistant to fluoroquinolones, respectively. The MICs of the fluoroquinolones against MS16968 and MS16996 were 64-to 128-fold and 16-to 32-fold higher, respectively, than those for ATCC 19433. Although obvious cross-resistance was also observed among the fluoroquinolones, the susceptibilities of these two isolates to nonquinolone agents were almost equal to that of ATCC 19433. Purification and properties of DNA gyrase. To determine whether the fluoroquinolone resistance in E. faecalis was due to an altered DNA gyrase, partially purified gyrases were prepared from ATCC 19433, MS16968, and MS16996 by affinity chromatography on novobiocin-Sepharose. Figure 1 shows the enzymatic properties of DNA gyrase from ATCC 19433. When fractions of the A and B subunits were assayed separately with relaxed pBR322 as a substrate (Fig.  1, lanes b and c) , no DNA supercoiling activity was observable. Supercoiling activity was observed only when the two subunits were combined (Fig. 1, lane d) . The specific activities of the purified subunits A and B were 5.7 x 103 and 1.0 x 104 U/mg of protein, respectively. The major protein bands in the A and B subunit preparations from ATCC 19433 were approximately 100,000 and 85,000 daltons, respectively (data not shown). These results indicate that the DNA gyrase of E. faecalis consists of two subunits, analogous to the DNA gyrases purified from E. coli, P. aeruginosa, B. subtilis, and M. luteus (39) . We tested the supercoiling activities of intergeneric hybrids prepared from isolated gyrase subunits of E. faecalis, B. subtilis, and E. coli. An (Fig. 1, lane 1) and the subunit B of E. faecalis with the subunit A of B. subtilis (Fig. 1, lane m) . This result provided evidence for the functional equivalence of E. faecalis and B. subtilis subunits. However, no interspecies complementation between E. faecalis subunits and E. coli subunits was observable with any combination of the subunits (Fig. 1, lanes q and r) . The E. faecalis gyrase was similar to the E. coli, M. luteus, or B. subtilis gyrase in its cofactor requirements. The supercoiling reaction absolutely required ATP and Mg2+ (Fig. 1 , lanes e and f) at optimum concentrations of 3 and 1.5 mM, respectively (Fig. 2) . A similar activity was obtained by the addition of Mn2+ or Ca2" in place of Mg2" (Fig. 1, lanes   g and h; Fig. 2) .
The A and B subunits from MS16968 and MS16996 were also separately purified by the same purification procedure, and their enzymatic properties were similar to those of the subunits from ATCC 19433.
Inhibition of DNA supercoiling activity. The inhibitory effects of ciprofloxacin on the DNA gyrases from ATCC 19433 and MS16968 are shown in Fig. 3 . With the DNA gyrase from strain ATCC 19433, some inhibition by ciprofloxacin was seen at 25 to 50 ,ug/ml (Fig. 3, lanes e and f) ; nearly complete inhibition was seen at 100 ,ug/ml (Fig. 3, lane  g ). On the other hand, ciprofloxacin did not inhibit the supercoiling activity of MS16968 gyrase even at 800 ,g/ml (Fig. 3, lane p) (Table 3) . Conversely, reconstitution of the B subunit of either MS16968 or MS16996 gyrase with the A subunit from ATCC 19433 (As+Brl or As+Br2 in Table 3 (As+Bs in Table 3 ). In contrast to the fluoroquinolones, but predictable from the MICs, the old quinolones nalidixic acid and pipemidic acid did not inhibit the supercoiling activity of any gyrase preparation. Novobiocin, a compound that competitively inhibits ATP binding to the B subunit (20) , was equally active against all gyrase preparations (IC50, 4 to 5 jig/ml).
Uptake of norfloxacin. The uptake of norfloxacin by ATCC 19433, MS16968, and MS16996 cells was compared (Fig. 4) . No (10, 45) and S. aureus (13) . However, in this study, the IC50s of the fluoroquinolones correlated well with their respective MICs, even though the IC50 was about 10 to 20 times higher than its respective MIC. This correlation has been observed in gram-negative bacteria. The IC50s of quinolones for the supercoiling activity of E. coli gyrase are generally one to two orders of magnitude greater than the corresponding MICs (7, 19, 24, 37 We compared the uptakes of norfloxacin by these resistant isolates with the uptake by ATCC 19433 to determine whether other factors contributed to the fluoroquinolone resistance. Our results indicate that an alteration in the cell permeability to fluoroquinolones is not the major contributor to fluoroquinolone resistance. However, a difference in the amount of drug uptake may account for the difference in the level of fluoroquinolone resistance between these two isolates. In a recent report, Kojima et al. (26) demonstrated incomplete cross-resistance among fluoroquinolones with ciprofloxacin-resistant, methicillin-resistant S. aureus isolates and speculated that changes in permeability or in the efflux of fluoroquinolones contributed significantly to the fluoroquinolone resistance in these strains. The outer membrane of gram-negative cells has been widely accepted to be a barrier to the penetration of quinolones into the bacterial cell (16, 21, 22, 36) . Since S. aureus does not have an outer membrane structure, Kojima et al. (26) also suggested that a barrier function might exist in the cytoplasmic membrane. Thus, it appears that the permeability or efflux of the drug may play a role in fluoroquinolone resistance in grampositive bacteria. With regard to gram-negative bacteria, an energy-dependent system located at the bacterial inner membrane has been found to decrease norfloxacin uptake in E. coli (6) . Further studies are needed to determine whether such a mechanism exits in gram-positive bacteria.
On the basis of these results, we conclude that one of the resistance mechanisms of E. faecalis against fluoroquinolones is an alteration in the DNA gyrase A subunit. Our study also shows the role of the DNA gyrase subunit A as the target for fluoroquinolones in E. faecalis. Recently, Hopewell et al. (23) have succeeded in cloning S. aureus genes which encode the DNA gyrase A and B proteins.
From the DNA sequence analysis, a close homology between the S. aureus gyrase subunits and their counterparts in B. subtilis and E. coli was observed, including several conserved amino acid residues whose substitution in E. coli confers resistance to fluoroquinolones. The application of a similar genetic approach will enable the elucidation of the mechanisms of fluoroquinolone resistance in E. faecalis at the molecular level.
